The Countess of Chester is the main NHS hospital for Chester and its surrounding area. It currently has 625 beds, general medical departments and a 24-hour accident and emergency unit. It is managed by the Countess of Chester Hospital NHS Foundation Trust, which was one of the first Foundation Trusts, formed in 2004.

There are 625 beds in Countess of Chester Hospital.

During the past decade, Countess of Chester Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Countess of Chester Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Countess of Chester NHS Foundation Trust" with 2 trials sponsored, "Queen Mary University of London" with 2 trials sponsored and "University of Leeds" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Countess of Chester Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Countess of Chester Hospital" are "Breast Cancer" (4 trials), "Atrial Fibrillation" (2 trials), "Leukemia" (2 trials), "Lymphoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Countess of Chester Hospital" in a lesser frequency.

Most popular intervention types in "Countess of Chester Hospital" are "Drug" (19 trials), "Other" (7 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "vincristine sulfate" (3 trials), "CHOP regimen" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Countess of Chester Hospital" are 26 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Countess of Chester Hospital". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Countess of Chester Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Countess of Chester Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".